The confidential unit exclusion and allogeneic blood donation

Results from supplementary questions to the donor center and viral markers surveys of the College of American Pathologists

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Objective. - The confidential unit exclusion (CUE) is a mechanism for allogeneic blood donors to confidentially indicate whether they feel their blood is safe for transfusion to others. The purpose of this national survey was to determine the extent of use of the CUE procedure and its related policies. Design. - Supplementary questions related to the use of the CUE were asked of those 1994 DC-C, W1-C, and W2-C College of American Pathologists survey subscribers who collect allogeneic blood for transfusion. Setting. - National survey. Participants. - Blood collection facilities who collect allogeneic blood components. Main Outcome Measures. - Survey responses. Results. - There were a total of 2966 total participants in the 1994 DC-C, W1-C, and W2-C surveys. A potential total of 444 participants indicated that they collected allogeneic blood and were eligible to participate in the CUE survey. A variety of approaches are used concerning donor deferral, reinstatement, and follow-up in the use of the CUE. Documentation and donor counseling issues also show variation. Conclusions. - Different approaches and procedures have been developed by collection facilities to address issues related to the use of the CUE. More data on the efficacy and cost-effectiveness of the CUE are needed.

Original languageEnglish (US)
Pages (from-to)1007-1011
Number of pages5
JournalArchives of Pathology and Laboratory Medicine
Volume119
Issue number11
StatePublished - Dec 1 1995

Fingerprint

Blood Donors
Biomarkers
Tissue Donors
Blood Transfusion
Documentation
Cost-Benefit Analysis
Pathologists
Surveys and Questionnaires
Counseling
Outcome Assessment (Health Care)

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine
  • Medical Laboratory Technology

Cite this

@article{e77a2f2c987c4e6da65b534118b31ade,
title = "The confidential unit exclusion and allogeneic blood donation: Results from supplementary questions to the donor center and viral markers surveys of the College of American Pathologists",
abstract = "Objective. - The confidential unit exclusion (CUE) is a mechanism for allogeneic blood donors to confidentially indicate whether they feel their blood is safe for transfusion to others. The purpose of this national survey was to determine the extent of use of the CUE procedure and its related policies. Design. - Supplementary questions related to the use of the CUE were asked of those 1994 DC-C, W1-C, and W2-C College of American Pathologists survey subscribers who collect allogeneic blood for transfusion. Setting. - National survey. Participants. - Blood collection facilities who collect allogeneic blood components. Main Outcome Measures. - Survey responses. Results. - There were a total of 2966 total participants in the 1994 DC-C, W1-C, and W2-C surveys. A potential total of 444 participants indicated that they collected allogeneic blood and were eligible to participate in the CUE survey. A variety of approaches are used concerning donor deferral, reinstatement, and follow-up in the use of the CUE. Documentation and donor counseling issues also show variation. Conclusions. - Different approaches and procedures have been developed by collection facilities to address issues related to the use of the CUE. More data on the efficacy and cost-effectiveness of the CUE are needed.",
author = "Ronald Domen",
year = "1995",
month = "12",
day = "1",
language = "English (US)",
volume = "119",
pages = "1007--1011",
journal = "Archives of Pathology and Laboratory Medicine",
issn = "0003-9985",
publisher = "College of American Pathologists",
number = "11",

}

TY - JOUR

T1 - The confidential unit exclusion and allogeneic blood donation

T2 - Results from supplementary questions to the donor center and viral markers surveys of the College of American Pathologists

AU - Domen, Ronald

PY - 1995/12/1

Y1 - 1995/12/1

N2 - Objective. - The confidential unit exclusion (CUE) is a mechanism for allogeneic blood donors to confidentially indicate whether they feel their blood is safe for transfusion to others. The purpose of this national survey was to determine the extent of use of the CUE procedure and its related policies. Design. - Supplementary questions related to the use of the CUE were asked of those 1994 DC-C, W1-C, and W2-C College of American Pathologists survey subscribers who collect allogeneic blood for transfusion. Setting. - National survey. Participants. - Blood collection facilities who collect allogeneic blood components. Main Outcome Measures. - Survey responses. Results. - There were a total of 2966 total participants in the 1994 DC-C, W1-C, and W2-C surveys. A potential total of 444 participants indicated that they collected allogeneic blood and were eligible to participate in the CUE survey. A variety of approaches are used concerning donor deferral, reinstatement, and follow-up in the use of the CUE. Documentation and donor counseling issues also show variation. Conclusions. - Different approaches and procedures have been developed by collection facilities to address issues related to the use of the CUE. More data on the efficacy and cost-effectiveness of the CUE are needed.

AB - Objective. - The confidential unit exclusion (CUE) is a mechanism for allogeneic blood donors to confidentially indicate whether they feel their blood is safe for transfusion to others. The purpose of this national survey was to determine the extent of use of the CUE procedure and its related policies. Design. - Supplementary questions related to the use of the CUE were asked of those 1994 DC-C, W1-C, and W2-C College of American Pathologists survey subscribers who collect allogeneic blood for transfusion. Setting. - National survey. Participants. - Blood collection facilities who collect allogeneic blood components. Main Outcome Measures. - Survey responses. Results. - There were a total of 2966 total participants in the 1994 DC-C, W1-C, and W2-C surveys. A potential total of 444 participants indicated that they collected allogeneic blood and were eligible to participate in the CUE survey. A variety of approaches are used concerning donor deferral, reinstatement, and follow-up in the use of the CUE. Documentation and donor counseling issues also show variation. Conclusions. - Different approaches and procedures have been developed by collection facilities to address issues related to the use of the CUE. More data on the efficacy and cost-effectiveness of the CUE are needed.

UR - http://www.scopus.com/inward/record.url?scp=0029582713&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029582713&partnerID=8YFLogxK

M3 - Article

VL - 119

SP - 1007

EP - 1011

JO - Archives of Pathology and Laboratory Medicine

JF - Archives of Pathology and Laboratory Medicine

SN - 0003-9985

IS - 11

ER -